User talk:Linberry

Welcome!

Hello, Linberry, and welcome to Wikipedia! Thank you for your contributions. I hope you like the place and decide to stay. Here are a few good links for newcomers:

I hope you enjoy editing here and being a Wikipedian! Please sign your name on talk pages using four tildes (~~~~); this will automatically produce your name and the date. If you need help, check out Wikipedia:Questions, ask me on my talk page, or place {{helpme}} on your talk page and someone will show up shortly to answer your questions. Again, welcome! RJFJR 14:58, 25 April 2006 (UTC)[reply]

Valproate[edit]

Thanks for your edits to the valproates. Don't be frightened about contributing more. In fact, starting a new article is perhaps less scary that editing a mature one. You could start with the red link drugs when you browse down from ATC Code. One help is to find a drug article that contains some of the style/tables/info that you want and steal the code from the edit window (being careful to fully replace everything that is different).

I noticed on Anxiolytic that you removed text "copied" from AbsoluteAstronomy. This is just a Wikipedia mirror (or gets some of its content from Wikipedia). So there was no copyright problem. If you use Firefox, see meta:Mirror filter to find a way of removing such sites from your Google searches (if you want this).

Nice to have another (trainee) expert working here to correct the mistakes us amateurs make. And from the best part of the UK too.

Colin°^Talk 09:56, 27 April 2006 (UTC)[reply]

New articles[edit]

You can practice in a sandbox from your user page and, of course, the Show preview and Show changes buttons are very useful – I use them all the time. It is worth browsing the edit code for several pages to get an idea of how things are done.

Anyone who has anything useful to contribute is probably also very busy. But don't neglect the real world. If there is an article you want to start, we could work on it togther. I can't of course, provide a medical professional opinion since I don't have one.

Your textbooks should be a good resource. You are welcome to refer to a paper book as a source but other readers may find that less useful if they want to check the facts – so an online reference is great. Not all of those are good - see my user page for some of the references I've used.

I am, of course, from the best bit of the best part of the UK. But that's all I want to say ;-)

The practice of talk page discussions on Wikipedia is strange and can lead to very disjointed and hard to follow (for a third party) conversations. A few people state at the top of their talk pages that they always respond on their own talk pages (unless requested otherwise). However, it appears the usual practice to respond on the other person's page. This is because most folk don't keep User talk pages in their watch list. Perhaps it feels a bit like spying on them, or reading their mail. If you think it is best to interleave your response with the other person's, then you could do that on your own page and put a little "I've responded on my talk page" on theirs. I'll leave you in my watch list for now if you like – so you can respond where you want.

BTW: it is normal to use == for headings on talk pages rather than =. You can use the + button (to the right of "edit this page") to start a new topic and it gives you a field for you to enter the title.

I liked your edit comment on diazepam. Don't you know anyone you'd like to do an LD₅₀ test on?

Colin°^Talk 18:40, 27 April 2006 (UTC)[reply]

Thanks for the info :) Didn't know about the + thing - to be honest this site is one of the most confusing places I've ever been to! Makes me feel like a right pillock.

Will try and use online references of course if I can - sometimes though, especially with the biology topics, info is very limited (many a time I have looked myself for an explanation of some weird unintelligible scientific term and there isn't one anywhere!) The more specialised you go, the harder it is, isn't it. Will try some of the links on your page.

LOL... so the only people who edit on this sites are the ones that don't have anything useful to contribute!

Berry 19:52, 27 April 2006 (UTC)[reply]

Adam Khan[edit]

Hi Berry thanks for the update about the post..I am not sure what to do the site owner may have coyrighted it..but the story of adam khan is the equivalent of romeo and juliet how do I not quote it exactly? The aryan site is citing another refernec on top of it..

thanks for the reply I've redone the piece and will add a link to the original story as well as try and get permission for it's reuse.--Zak 20:33, 6 May 2006 (UTC)[reply]

WP:CVU status[edit]

The Wikipedia:Counter-Vandalism Unit project is under consideration to be moved to {{inactive}} and/or {{historical}} status. Another proposal is to delete or redirect the project. You have been identified as a project member and your input as to this matter would be welcomed at WT:CVU#Inactive.3F and at the deletion debate. Thank you! Delivered on behalf of xaosflux 17:01, 10 August 2007 (UTC)[reply]

WikiProject Pharmacology Collaboration of the Week[edit]

WikiProject Pharmacology is currently organizing a new Collaboration of the Week program, designed to bring drug and medication related articles up to featured status. We're currently soliciting nominations and/or voting on nominations for the first WP:RxCOTW, to begin on September 5, 2007. Please stop by the Pharmacology Collaboration of the Week page to participate! Thanks! Dr. Cash 17:51, 1 September 2007 (UTC)[reply]

Pharmacology Collaboration of the Week[edit]

Aspirin has been selected as this week's Pharmacology Collaboration of the Week! Please help us bring this article up to featured standards during the week. The goal is to nominate this at WP:FAC on September 10, 2007.

Also, please visitWP:RxCOTW to support other articles for the next COTW. Articles that have been nominated thus far include Doxorubicin, Paracetamol (in the lead with 4 support votes so far), Muscle relaxant, Ethanol, and Bufotenin.

In other news:

Bupropion has been promoted to featured status on August 31, 2007.

The Wikipedia:WikiProject Pharmacology main page has been updated and overhauled, to make it easier to find things, as well as to highlight other goals and announcements for the project.

Garrondo is asking for individuals to help review Therapies for multiple sclerosis, as he is considering nominating this article for GA status.

Fvasconcellos notes that discussion is ongoing regarding the current wording of MEDMOS on including dosage information in drug articles. All input is welcome.

Dr. Cash 00:49, 5 September 2007 (UTC)[reply]

WikiProject Pharmacology Update[edit]

Here's a brief update in some of the recent developments of WikiProject Pharmacology!

Aspirin has just completed its two week run as the first Collaboration of the Week! Many thanks to those editors that contributed; the article got a lot of good work accomplished, and in particular, much work was done in fixing up the history section. It's still not quite "done" yet (is a wikipedia article really ever done?), but after two weeks I think it's more important to push onwards with the development of the new collaboration of the week program. I will be fixing up Aspirin in the next few days and possibly nominating it for either GA or FA status.

Muscle relaxant has been selected as the new Collaboration of the week until October 2, 2007! This article is currently rated as a "stub", so it's got quite a bit of work cut out for collaborators! Admittedly, featured status could be a long way off,... but still attainable! At the least, maybe we could at least get it up to meeting the Good article criteria? Please stop by the article and help improve it.

Resveratrol, having recently achieved GA status on August 16, 2007, is now making a run for featured status. This is quite a fascinating compound. If you can, please stop by its discussion page and leave comments in support of it.

Please remember that Wikipedia is not a forum for discussing or dispensing medical advice amongst users. Specifically, talk pages of articles should only be used to discuss improving the actual article in question. To help alleviate this situation, the template {{talkheader}} may be added to the top of talk pages, reminding users of the purpose of such pages. Additionally, unsigned comments and comments by anonymous users that are inappropriate may be removed from talk pages without being considered vandalism.

There was an interesting article on ZDNet last week about Hewlett Packard licensing its patented microneedle technology used in common inkjet printers to be used in transdermal patches to deliver a time-controlled release of drugs to patients. This information could be added to articles such as route of administration or drug delivery.

You are receiving this message because you are listed as one of the participants of WikiProject Pharmacology.

Dr. Cash 04:58, 19 September 2007 (UTC)[reply]

WikiProject Pharmacology Update[edit]

Here are a few updates in the realm of WikiProject Pharmacology:

The Pharmacology Collaboration of the Week has been changed to Collaboration of the Month, based on current participation levels. It is also more likely that articles collaborated on for one month are more likely to achieve featured quality than articles worked on for only a week or two.

The current Collaboration of the Month for November is Receptor antagonist. Please take a look at that article and contribute to it if you get a chance. Ideally, the article should adhere to the featured article criteria.

Therapies for multiple sclerosis is currently a featured article candidate. If you are familiar with the featured article criteria, please visit WP:FAC and review the article.

Anabolic steroid is the wikiproject's newest Featured Article, having been promoted on October 8, 2007.

Theobromine was delisted as a Good Article. The Peer review and GA reassessment discussions provide suggestions on improvement. Muscle relaxant was recently reviewed for Good Article status, but not promoted. Please see the full review full review here for details.

Dr. Cash 22:13, 31 October 2007 (UTC)[reply]

Research survey invitation[edit]

Greetings Linberry-

My name is Randall Livingstone, and I am a doctoral student at the University of Oregon, studying digital media and online community. I am posting to invite you to participate in my research study exploring the work of Wikipedia editors who are members of WikiProject: Countering Systemic Bias. The online survey should take 20 to 25 minutes to complete and can be found here:

https://oregon.qualtrics.com/SE/?SID=SV_cSHzuwaQovaZ6ss

Your responses will help online communication researchers like me to better understand the collaborations, challenges, and purposeful work of Wikipedia editors like you. In addition, at the end of the survey you will have the opportunity to express your interest in a follow-up online interview with the researcher.

This research project has been reviewed and approved by the Wikimedia Research Committee as well as the Office for Protection of Human Subjects at the University of Oregon. For a detailed description of the project, please visit its Meta page. This survey is voluntary, and your confidentiality will be protected. You will have the choice of using your Wikipedia User Name during the research or creating a unique pseudonym. You may skip any question you choose, and you may withdraw at any time. By completing the survey, you are providing consent to participate in the research.

If you have any questions about the study, please contact me via my Talk Page (UOJComm) or via email. My faculty advisor is Dr. Ryan Light. If you have any questions regarding your rights as a research participant, please contact the Office for Protection of Human Subjects at the University of Oregon.

Thank you very much.

Sincerely,

Randall Livingstone School of Journalism & Communication University of Oregon UOJComm (talk) 04:12, 22 June 2011 (UTC)[reply]

The Wikipedia Library now offering accounts from Cochrane Collaboration (sign up!)[edit]

Cochrane Collaboration is an independent medical nonprofit organization consisting of over 28,000 volunteers in more than 100 countries. The collaboration was formed to organize medical scholarship in a systematic way in the interests of evidence-based research: the group conducts systematic reviews of randomized controlled trials of health-care interventions, which it then publishes in the Cochrane Library.

Cochrane has generously agreed to give free, full-access accounts to 100 medical editors. Individual access would otherwise cost between $300 and $800 per account. Thank you Cochrane!

If you are stil active as a medical editor, come and sign up :)

Cheers, Ocaasi^{t | c} 19:51, 16 June 2013 (UTC)[reply]